D - Purchase Description.pdf
PDF 149 KB Posted
- Solicitation number
- 75N95024Q00370
About this file
This document is a Purchase Description for a federal contract opportunity to purchase PromethION Flow Cells (or equal) and Ligation Sequencing Kits (or equal) issued by the Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse.
The purpose of the acquisition is to leverage the high-throughput, long-read sequencing capabilities of the PromethION platform for single-cell genomic analysis. Key objectives include enhancing resolution of genetic information, enabling real-time data analysis, achieving high-throughput sequencing, reducing sequencing costs, and utilizing the platform's versatility across various genomic applications. The requirement is for 15 PromethION Flow Cell Packs and 12 Ligation Sequencing Kits, with a 30-day delivery after receipt of order and a 1-year manufacturer warranty. The solicitation is issued as a Request for Quotation under simplified acquisition procedures, with a response due date of August 8, 2024. Award will be made to the responsible offeror whose quote conforming to the solicitation will be most advantageous to the Government, with technical capability and past performance being significantly more important than price.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Version 11-30-2016-1 FAR Part 11—Describing Agency Needs
PURCHASE DESCRIPTION
1. Statement of Need and Purpose: The purpose of this acquisition is to purchase the Promethion Flow cells (or equal).
2. Background Information and Objective: Nanopore PromethION flow cells, developed by Oxford Nanopore Technologies, represent a groundbreaking advancement in the field of genomics. Nanopore sequencing technology enables the direct, real-time analysis of long DNA and RNA molecules as they pass through nanopores. This method offers significant advantages over traditional short-read sequencing technologies, including the ability to generate ultra-long reads, high throughput, and real-time data acquisition.
PromethION, one of the most powerful platforms within the nanopore sequencing family, is designed for large-scale, high-throughput applications, making it ideal for comprehensive genomic studies.
The PromethION system is particularly well-suited for single-cell sequencing, a technique that allows researchers to investigate the genetic material of individual cells.
Single-cell sequencing has become a crucial tool in various fields, including cancer research, immunology, neurobiology, and developmental biology, as it provides insights into cellular heterogeneity and the underlying mechanisms of complex biological processes. Traditional sequencing methods often miss critical genetic variations due to the averaging effect of bulk sequencing, but single-cell sequencing can capture these variations, offering a more detailed and accurate picture of cellular function and diversity.
The primary objective of using Nanopore PromethION flow cells is to leverage their high-throughput, long-read sequencing capabilities for single-cell genomic analysis.
Specific objectives include:
Enhanced Resolution of Genetic Information: To achieve a deeper understanding of genetic diversity and complexity within individual cells by capturing full-length transcripts, structural variations, and repetitive regions that are often missed by short-read sequencing technologies.
Real-Time Data Analysis: To enable immediate analysis of sequencing data, facilitating quicker decision-making and hypothesis testing in research projects.
High-Throughput Sequencing: To efficiently process large numbers of single-cell samples simultaneously, ensuring comprehensive coverage and statistically robust data.
Cost-Effective Sequencing: To reduce the cost per base of sequencing by maximizing the data output per run, making large-scale single-cell studies more economical.
Versatility Across Applications: To utilize the PromethION platform's versatility for various genomic applications, including metagenomics, epigenetics, and transcriptomics, thereby expanding the scope of research possibilities.
Version 11-30-2016-1 FAR Part 11—Describing Agency Needs
Simplified Workflow: To streamline the sequencing workflow with minimal sample preparation requirements, preserving sample integrity and reducing potential errors.
Community and Support Utilization: To take advantage of Oxford Nanopore Technologies' robust support network and active user community for resources, protocols, and collaborative opportunities, enhancing the efficiency and success of research projects.
By achieving these objectives, researchers aim to push the boundaries of genomic science, uncovering novel insights into cellular functions, genetic mechanisms, and disease pathways, ultimately advancing the field of personalized medicine and therapeutic development.
3. Generic Name of Product: PromethION Flow Cell Packs and Ligation Sequencing Kits
4. Salient characteristics:
PromethION Flow Cells Packs (R10.4.1) (or equal), Cat# FLO-PRO114M; Ligation Sequencing Kit V14, Cat# SQK-LSK114 (or equal)
a. Profile gene expression.
b. Achieve deep characterization of cell types and states with linked transcriptomic and epigenomic analyses.
c. Easy-to-use software for data analysis and visualization
5. Quantity: Fifteen (15) PromethION Flow Cell Packs and twelve (12) Ligation Sequencing Kits
6. Delivery Date: The delivery date is within 30 days after receipt of purchase order.
7. Period of Performance: Manufacturer warranty is required for one calendar year beginning date of receipt.
File details come from the government source that posted it. Updated .